Position in CDXS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$59,092
New position
Shares Held
36,253
first reported quarter
Ownership
0.040%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Frec Markets, Inc. holds $3,351,606 across 11 Biotechnology names. CDXS ranks #9 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,048 | $809,726 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,535 | $685,438 | |
| 3 | INCY |
Incyte Corp
|
6,334 | $596,156 | |
| 4 | EXEL |
Exelixis, Inc.
|
7,587 | $325,406 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
4,732 | $267,310 | |
| 6 | BHVN |
Biohaven Ltd.
|
25,681 | $217,261 | |
| 7 | RPRX |
Royalty Pharma plc
|
4,486 | $215,193 | |
| 8 | RCKT |
Rocket Pharmaceuticals, Inc.
|
18,176 | $65,070 |
All Filings in CDXS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,092 | 36,253 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||